Big Ticket Federal & Illinois Laws & Regulations | McDermott Skip to main content

Big Ticket Federal and Illinois Laws and Regulations That Transactional Health Care Lawyers Must Know

Big Ticket Federal and Illinois Laws and Regulations That Transactional Health Care Lawyers Must Know

Overview


Strategic corporate transactions that involve hospitals and health systems are subject to a plethora of federal, state, and local laws and regulations. The high level of governmental oversight requires that hospital/health system transactions have separate signings and closings to allow sufficient time for the parties to accommodate the many filings, notices, consents, and other governmental approvals that are necessary to close the transaction as well as operate the business effectively after closing.

The presentation highlights the “big ticket” federal and Illinois laws and regulations that you need to know to be an effective hospital/health system deal lawyer as well as best practices for efficiently getting over the closing finish line. Associate Sumaya Noush will speak on the panel.

Health care, government, and corporate lawyers with basic to intermediate practice experience who attend this online program will better understand:

  • Federal and Illinois laws and regulations that loom large for strategic corporate transactions that involve hospitals and health systems;
  • Best practices for efficiently and effectively navigating the executory period between signing and closing; and
  • Consequences for failing to meet governmental requirements for closing a hospital/health system transaction.

Click to learn more!

Dig Deeper

Brussels, Belgium / Speaking Engagements / May 21, 2026

EU Pharmaceutical Law Forum 2026

San Francisco, CA / In-person / April 30, 2026

Health Tech Investment Forum 2026

Orlando, FL / Speaking Engagements / April 23 – 24, 2026

NAMCP 2026 Spring Managed Care Forum

Miami, FL / In-person / March 4-5, 2026

HPE Miami 2026

Webinar / Webinar / February 25, 2026

ISO 13485 Compliance for Medical Device Companies

Paris, France / DeepLife / February 19, 2026

Infinite 2026: Unlocking new value in existing therapies